Cempra

Cempra Pharmaceuticals is a clinical-stage pharmaceutical company focused on developing antibacterials to meet critical medical needs.

[Cempra @Cempra1]

FDA Grants Fast Track Designation to Cempra for Solithromycin in the Treatment of CABP http://t.co/2sQ310vdr3

[Cempra @Cempra1]

Cempra to Present at the Wedbush PacGrow 2015 Healthcare Conference http://t.co/95hVtEz68M

[Cempra @Cempra1]

Cempra Reports Second Quarter 2015 Financial Results and Provides Corporate Update http://t.co/bl0r8yrYHH

[Cempra @Cempra1]

Cempra to Report Second Quarter 2015 Financial Results http://t.co/NSkzo36mK2

[Cempra @Cempra1]

Cempra Completes Patient Enrollment of Solitaire-IV Phase 3 Clinical Trial

http://t.co/8aw9fLGuRQ

[Cempra @Cempra1]

Cempra Presenting Additional Data From the Phase 3 Oral Solithromycin Study in CABP at #ATS2015 http://t.co/LdJvv66rQf

[Cempra @Cempra1]

Cempra to Present Solithromycin Data at Two Upcoming Medical Conferences http://t.co/yYQVO8HW9j

[Cempra @Cempra1]

Cempra Reports First Quarter 2015 Financial Results and Provides Corporate Update http://t.co/mfDF1FCHTl

[Cempra @Cempra1]

Cempra to Participate in Jefferies 2015 Antibiotic Summit Investor Conference http://t.co/vqT7X46FWt

[Cempra @Cempra1]

Cempra Reports Fourth Quarter and Full Year 2014 Financial Results and Provides Corporate Update http://t.co/oH5m704Nzz

[Cempra @Cempra1]

Cempra to Report Fourth Quarter and Full Year 2014 Financial Results http://t.co/8iHGAVKXxO

[Cempra @Cempra1]

Cempra to Present at Three Upcoming Investor Conferences http://t.co/qPZm6Y9SmV

[Cempra @Cempra1]

Cempra Prices Public Offering of Common Stock http://t.co/ydU0GHXqOn

[Cempra @Cempra1]

Cempra Announces Proposed Public Offering of $100 Million of Common Stock http://t.co/UfzzSFPxgZ

[Cempra @Cempra1]

Cempra Announces Positive Topline Phase 3 Clinical Results for Oral Solithromycin in the Treatment of CABP http://t.co/L8p8CUm9on

[Cempra @Cempra1]

Cempra to Receive BARDA Funding for 1b and Start-Up of Phase 2/3 Solithromycin Pediatric Studies http://t.co/jE9JgR2NhA

[Cempra @Cempra1]

Cempra to present at two upcoming investor conferences http://t.co/Qx9SnFOBwb

[Cempra @Cempra1]

Cempra reports 3Q’14 financial & operating results; to host conference call and webcast at 4:30 p.m. EDT, today http://t.co/YxefQxzNgY …

[Cempra @Cempra1]

Cempra to report 3Q’14 financial & operating results and host conference call & webcast on October 29 http://t.co/2ug1wOYuZF

[Cempra @Cempra1]

Cempra completes enrollment of Solitaire-Oral Phase 3 trial http://t.co/qyh63ZL1Pv